On May 25, the "2022 China Japan medical health exchange meeting" was held online, which was jointly sponsored by China food and drug International Exchange Center, the central biotechnology and pharmacy Working Committee of the agricultural labor party and the Central Youth Working Committee of the agricultural labor party. Qufenghong, Deputy Secretary General of the Chinese people's Political Consultative Conference and full-time vice chairman of the Central Committee of the agricultural labor party, zhaojunning, deputy director of the State Food and drug administration, Kanghong Fujiwara, chairman of Japan's comprehensive agency for drugs and medical devices (PMDA), and ligunho Li, chairman of Japan's Medical Excellence Agency (Mej), attended and addressed the meeting.

The "2022 China Japan medical and health exchange meeting" held exchanges and discussions on such hot issues as the implementation of the drug administration law, the emergency response to the COVID-19, the reform of the review and approval system for drugs and medical devices, and the review of cell and gene therapy products. Leaders from the regulatory department, drug registration department, drug supervision department, drug evaluation center and medical device evaluation center of the State Drug Administration made wonderful speeches at the meeting. More than 3000 Chinese and Japanese experts and enterprises in related fields participated in the online conference.

Mr. guanqingwei, as a member of the Central Youth Working Committee of the rural labor party, presided over the first session of the afternoon meeting. As early as 2018, Mr. guanqingwei planned and prepared China Japan exchange activities and successfully organized the "2018 medical and health experts' seminar". Mr. Tatsuya Kondo, then the president of PMDA, made a special trip to China to discuss the development of the health field with relevant domestic experts. In april2019, Mr. Kanghong Fujiwara, President of PMDA, just took office. Mr. guanqingwei made a special trip to Japan to communicate with China Japan medical and health exchange. After reaching a consensus, he successfully held the "2020 China Japan medical and health exchange meeting" on January 6, 2020. The "2022 China Japan medical and health exchange meeting" was originally scheduled to be held in Boao, Hainan on December 24, 2021, but was repeatedly postponed due to the epidemic situation. During this period, Mr. guanqingwei and Mr. Fujiwara Kanghong, the president of PMDA, discussed the organization of the meeting for many times to promote the smooth holding of the meeting.

  At the hosting session of Mr. guanqingwei, he expressed deep condolences for the death of Mr. Tatsuya Kondo, the former president of Japan's drug and device comprehensive agency (PMDA) and Japan's Medical Excellence Agency (Mej). Mr. Tatsuya Kondo is his mentor and helpful friend. Since 2017, he has carried out many exchanges and communication with him and established a deep friendship. It is also under the promotion of Mr. Tatsuya Kondo that the two consecutive China Japan medical and health exchange meetings were successfully held. He also gave great support to the 2022 China Japan medical and health exchange conference. Mr. Kondo has made great contributions to the promotion and development of medical and health exchanges between China and Japan.